SAVE JON, Inc.

The mission of SAVE JON, Inc. is to understand and cure a rare liver and bile duct disease called Primary Sclerosing Cholangitis (PSC) in time to save the lives of patients currently suffering from this disease. We do this through an actively managed portfolio of interdependent research and clinical development programs designed to deliver new therapeutic trials to our patients in five years’ time. In order to achieve this goal, our 501c3 nonprofit organization coordinates large multinational projects to accelerate the pace of developing solutions for PSC patients.